Oramed Pharmaceuticals, Inc. (ORMP)
3.305
-0.08
(-2.22%)
USD |
NASDAQ |
Feb 11, 10:37
Oramed Pharmaceuticals EPS Diluted (Quarterly) : 1.131 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifeward Ltd. | -0.1979 |
| Bristol Myers Squibb Co. | 0.5326 |
| Instil Bio, Inc. | -2.011 |
| Nektar Therapeutics | -1.875 |
| Innoviva, Inc. | 1.082 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 48.39M |
| Total Expenses (Quarterly) | -48.40M |
| Enterprise Value | -0.2466M |
| Earnings Yield | 30.34% |
| Normalized Earnings Yield | 16.90 |